Testing Nivolumab in Combination With Decitabine and Venetoclax in Patients With Newly Diagnosed TP53 Gene Mutated Acute Myeloid Leukemia
Clinical trial NCT04277442 · COMPLETED
Trial details
- NCT number
- NCT04277442
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-11
- Primary completion
- 2020-05-12
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.